Medartis Holding Management

Management criteria checks 3/4

Medartis Holding's CEO is Christoph Bronnimann, appointed in Sep 2019, has a tenure of 4.58 years. total yearly compensation is CHF1.87M, comprised of 26.8% salary and 73.2% bonuses, including company stock and options. directly owns 0.27% of the company’s shares, worth CHF2.99M. The average tenure of the management team and the board of directors is 3.3 years and 3 years respectively.

Key information

Christoph Bronnimann

Chief executive officer

CHF1.9m

Total compensation

CEO salary percentage26.8%
CEO tenure4.6yrs
CEO ownership0.3%
Management average tenure3.3yrs
Board average tenure3yrs

Recent management updates

Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

Apr 11
Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

Recent updates

Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

Apr 11
Shareholders Will Probably Not Have Any Issues With Medartis Holding AG's (VTX:MED) CEO Compensation

The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence

Feb 14
The Returns On Capital At Medartis Holding (VTX:MED) Don't Inspire Confidence

Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Oct 24
Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Is Medartis Holding (VTX:MED) A Risky Investment?

Oct 03
Is Medartis Holding (VTX:MED) A Risky Investment?

Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value

Sep 06
Is Medartis Holding AG (VTX:MED) Expensive For A Reason? A Look At Its Intrinsic Value

Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)

Jun 21
Market Still Lacking Some Conviction On Medartis Holding AG (VTX:MED)

Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital

Jan 31
Medartis Holding (VTX:MED) May Have Issues Allocating Its Capital

Why Medartis Holding AG (VTX:MED) Could Be Worth Watching

Oct 30
Why Medartis Holding AG (VTX:MED) Could Be Worth Watching

These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat

Sep 07
These Analysts Think Medartis Holding AG's (VTX:MED) Sales Are Under Threat

When Should You Buy Medartis Holding AG (VTX:MED)?

Jul 29
When Should You Buy Medartis Holding AG (VTX:MED)?

Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

May 06
Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?

Feb 08
At CHF123, Is It Time To Put Medartis Holding AG (VTX:MED) On Your Watch List?

Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

Jan 18
Medartis Holding (VTX:MED) Will Be Hoping To Turn Its Returns On Capital Around

We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt

Nov 10
We Think Medartis Holding (VTX:MED) Can Stay On Top Of Its Debt

Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

Sep 29
Medartis Holding (VTX:MED) Could Be Struggling To Allocate Capital

Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital

Jun 08
Some Investors May Be Worried About Medartis Holding's (VTX:MED) Returns On Capital

How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?

Mar 16
How Much Of Medartis Holding AG (VTX:MED) Do Insiders Own?

We're Watching These Trends At Medartis Holding (VTX:MED)

Feb 09
We're Watching These Trends At Medartis Holding (VTX:MED)

Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain

Jan 04
Medartis Holding (VTX:MED) Shareholders Have Enjoyed A 10% Share Price Gain

What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?

Nov 19
What Type Of Shareholders Own The Most Number of Medartis Holding AG (VTX:MED) Shares?

CEO Compensation Analysis

How has Christoph Bronnimann's remuneration changed compared to Medartis Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023CHF2mCHF500k

CHF619k

Sep 30 2023n/an/a

-CHF3m

Jun 30 2023n/an/a

-CHF7m

Mar 31 2023n/an/a

-CHF6m

Dec 31 2022CHF2mCHF500k

-CHF6m

Sep 30 2022n/an/a

-CHF3m

Jun 30 2022n/an/a

-CHF241k

Mar 31 2022n/an/a

CHF3m

Dec 31 2021CHF3mCHF500k

CHF7m

Sep 30 2021n/an/a

CHF9m

Jun 30 2021n/an/a

CHF12m

Mar 31 2021n/an/a

CHF6m

Dec 31 2020CHF2mCHF467k

-CHF944k

Sep 30 2020n/an/a

-CHF3m

Jun 30 2020n/an/a

-CHF4m

Mar 31 2020n/an/a

-CHF1m

Dec 31 2019CHF782kCHF168k

CHF2m

Compensation vs Market: Christoph's total compensation ($USD2.04M) is above average for companies of similar size in the Swiss market ($USD1.35M).

Compensation vs Earnings: Christoph's compensation has been consistent with company performance over the past year.


CEO

Christoph Bronnimann (57 yo)

4.6yrs

Tenure

CHF1,866,937

Compensation

Dr. Christoph Bronnimann is Chief Executive Officer at Medartis AG since September 2019. He has been the Chief Executive Officer and Member of Executive Management Board at Medartis Holding AG since Septem...


Leadership Team

NamePositionTenureCompensationOwnership
Christoph Bronnimann
CEO & Member of Executive Management Board4.6yrsCHF1.87m0.27%
CHF 3.0m
Thomas Straumann
Founder & Vice Chairman26.3yrsCHF291.97k41.48%
CHF 459.0m
Dirk Kirsten
CFO & Member of the Executive Management Board3.1yrsno data0.029%
CHF 324.1k
Mareike Loch
VP of EMEA & Member of Executive Management Board3.7yrsno data0.054%
CHF 592.8k
Manuel Schaer
CTO & Member of the Executive Board3.4yrsno data0.017%
CHF 188.2k
Mario Casa
COO & Member of Management Board2.3yrsno data0.0027%
CHF 29.7k
Inge Maes
Chief Human Resources Officer & Executive Management Board Memberno datano datano data
Fabian Hildbrand
Head of Corporate Communicationsno datano datano data
Anisha Wharton
Head of Regulatory Affairs3.1yrsno datano data

3.3yrs

Average Tenure

54yo

Average Age

Experienced Management: MED's management team is considered experienced (3.3 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Thomas Straumann
Founder & Vice Chairman26.3yrsCHF291.97k41.48%
CHF 459.0m
Damien Tappy
Independent Non-Executive Director6.3yrsCHF188.29k0.19%
CHF 2.1m
Marco Gadola
Independent Chairman4yrsCHF568.06k0.065%
CHF 721.4k
Ciro Roemer
Independent Director2yrsCHF112.76k0.0097%
CHF 106.8k
Willi Miesch
Independent Non Executive Director14.3yrsCHF161.68k0%
CHF 0
Martha Shadan
Independent Non-Executive Directorno datano datano data
Jennifer Dean
Independent Non-Executive Directorno datano datano data
Nadia Schmidt
Independent Director2yrsCHF171.53k0.0072%
CHF 80.1k

3.0yrs

Average Tenure

59.5yo

Average Age

Experienced Board: MED's board of directors are considered experienced (3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.